ArticleMolecular and cellular biochemistry2026
Embryo-fetal and early-life protein restriction programs pulmonary structure and molecular parameters in both dams and female offspring.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Developmental Origins of Health and Disease (DOHaD) theory proposes that adverse conditions during critical developmental windows can increase disease susceptibility throughout life. Maternal protein restriction (MPR) is a well-established experimental model that impairs offspring lung development, affecting pulmonary structure, metabolism, and molecular pathways from early life to aging. However, little is known about its effects on maternal pulmonary health and female offspring, representing an important gap in the literature. Therefore, this study investigated the effects of MPR on lung structure and metabolism in dams at the end of lactation and in female offspring at weaning. Sprague Dawley rats were fed either a control diet (17% protein) or a low-protein diet (6% protein) throughout gestation and lactation. Dams and female offspring were euthanized at weaning, and pulmonary alterations were assessed through histological, biochemical, molecular, zymographic, and in silico analyses. MPR increased collagen deposition, mast cell density, and Acta expression, while reducing reticular fibers in maternal lungs, accompanied by a trend toward increased lipid peroxidation. In female offspring, MPR reduced alveolar diameter, mast cell density, and reticular fibers, while increasing collagen deposition, MMP-2 activity, PI3K and MyoD expression, and decreasing mTOR expression as well as Nduf transcript levels. No significant alterations in antioxidant parameters were observed in either dams or offspring. Integrative analyses indicate that MPR promotes structural remodeling in maternal lungs, potentially compromising ventilatory function. In female offspring, MPR induces delayed pulmonary development, extracellular matrix remodeling, alterations in smooth muscle-related pathways, and disturbances in energy metabolism. Together, these findings demonstrate that maternal protein resQ1triction adversely affects pulmonary health in both dams and female offspring, revealing potential mechanisms linking early-life nutritional adversity to the developmental origins of respiratory disease.
Indexed as
Identifiers
42496845What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.